WILLIAM DEMPSEY: Open Payments
NPI 1821062985 · SOUTH ABINGTON TOWNSHIP, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 30 payments from 8 companies in 2025. Trend: 2023 $747 · 2024 $770 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $195 |
| Eisai Inc. | 7 | $138 |
| Indivior Inc. | 4 | $88 |
| PFIZER INC. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: Leqembi, VRAYLAR, SUBLOCADE, QULIPTA, UBRELVY, PREVNAR 20, AREXVY, FARXIGA.
Industry payments across PA — which companies pay providers there.
